Does Betaine Anhydrous Help With Betaine anhydrous is an FDA-approved treatment for homocy...?

Evidence Summary

Betaine anhydrous is an FDA-approved treatment for homocystinuria, where it reduces plasma homocysteine levels by approximately 29% (PMID: 30871635). In small pilot studies, it has shown promise for liver conditions including nonalcoholic steatohepatitis (NASH), with significant improvements in liver enzymes (AST and ALT) and histological markers after 12 months (PMID: 11569700), and reduced hepatic fat percentage in short bowel syndrome-associated hepatopathy (PMID: 24972476). It functions as a methyl group donor in transmethylation reactions and acts as an osmolyte in tissues (PMID: 32625971).

Source: auto-research

Effective Dose

6-10 g/day for medical conditions (homocystinuria, NASH, SBS); No established dose for general fitness/wellness use based on provided studies